COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 2064: Articles 20631-20640  | Next

Circulating ACE2-expressing Exosomes Block SARS-CoV-2 Virus Infection as an Innate Antiviral Mechanism
El-Shennawy, L., Hoffmann, A. D., Dashzeveg, N. K., Mehl, P. J., Yu, Z., Tokars, V. L., Nicolaescu, V., Ostiguin, C., Jia, Y., Li, L., Furlong, K., Mao, C., Wysocki, J., Batlle, D., Hope, T. J., Shen, Y., Luo, Y., Chae, Y., Zhang, H., Swaminathan, S., Randall, G. C., Demonbreun, A. R., Ison, M. G., Fang, D., Liu, H.
10.1101/2020.12.03.407031 — Posted: 2020-12-04
Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC
Yoon, H. a., Bartash, R., Gendlina, I., Rivera, J., Nakouzi, A., Bortz, R. H., Wirchnianski, A. S., Paroder, M., Fehn, K., Serrano-Rahman, L., Babb, R., Sarwar, U. N., Haslwanter, D., Laudermilch, E., Florez, C., Dieterle, M. E., Jangra, R. K., Fels, J. M., Tong, K., Mariano, M. C., Vergnolle, O., Georgiev, G. I., Herrera, N. G., Malonis, R. J., Quiroz, J. A., Morano, N. C., Krause, G. J., Sweeney, J. M., Cowman, K., Allen, S., Annam, J., Applebaum, A., Barboto, D., Khokhar, A., Lally, B. J., Lee, A., Lee, M., Malaviya, A., Sample, R., Yang, X. A., Li, Y., Ruiz, R., Thota, R., Barnhill, J., Goldstein, D. Y., Uehlinger, J., Garforth, S. J., Almo, S. C., Lai, J. R., Gil, M. R., Fox, A. S., Chandran, K., Wang, T., Daily, J. P., Pirofski, L.-a.
10.1101/2020.12.02.20242909 — Posted: 2020-12-04
Longitudinal lab test analysis confirms pre-existing anemia as a severe risk factor for post-viral clearance hospitalization in COVID-19 patients
Lenehan, P., Ramudu, E., Venkatakrishnan, A., O'Horo, J., Badley, A. D., Morice, W. G., Soundararajan, V.
10.1101/2020.12.02.20242958 — Posted: 2020-12-04
Mapping each pre-existing conditions association to short-term and long-term COVID-19 complications
Venkatakrishnan, A., Pawlowski, C., Zemmour, D., Hughes, T., Anand, A., Berner, G., Kayal, N., Puranik, A., Conrad, I., Bade, S., Barve, R., Sinha, P., O'Horo, J., Badley, A. D., Soundararajan, V.
10.1101/2020.12.02.20242925 — Posted: 2020-12-04
Determinants of COVID-19 Incidence and Mortality in the US: Spatial Analysis
Kathe, N., Wani, R. J.
10.1101/2020.12.02.20242685 — Posted: 2020-12-04
Food insecurity during COVID-19: A multi-state research collaborative
Niles, M. T., Belarmino, E. H., Bertmann, F., Biehl, E., Acciai, F., Josephson, A. L., Ohri-Vachaspati, P., Neff, R.
10.1101/2020.12.01.20242024 — Posted: 2020-12-04
Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19
O Gallagher, K., Shek, A., Bean, D. M., Bendayan, R., Teo, J. T., Dobson, R. J., Shah, A. M., Zakeri, R.
10.1101/2020.12.02.20242933 — Posted: 2020-12-04
The effectiveness of population-wide, rapid antigen test based screening in reducing SARS-CoV-2 infection prevalence in Slovakia
Pavelka, M., van Zandvoort, K., Abbott, S., Sherratt, K., Majdan, M., CMMID COVID-19 working group, , Institut Zdravotnych Analyz, , Jarcuska, P., Krajci, M., Flasche, S., Funk, S.
10.1101/2020.12.02.20240648 — Posted: 2020-12-04 Discussion: Onsite | Offsite
Nasopharyngeal microbial communities of patients infected with SARS-COV-2 that developed COVID-19.
Ventero, M. P., Cuadrat, R. R. C., Vidal, I., Andrade, B. G. N., Molina-Pardines, C., Haro-Moreno, J. M., Coutinho, F. H., Merino, E., Regitano, L. C., Silveira, C. B., Afli, H., Lopez-Perez, M., Rodriguez, J. C.
10.1101/2020.12.01.407486 — Posted: 2020-12-04 Discussion: Onsite
Modelling the Test, Trace and Quarantine Strategy to Control the COVID-19 Epidemic in the State of Sao Paulo, Brazil
Amaku, M., Covas, D. T., Coutinho, F. A. B., Azevedo, R. S., Struchiner, C., Wilder-Smith, A., Massad, E.
10.1101/2020.12.02.20242743 — Posted: 2020-12-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).